Ranibizumab

• CAT Number: I044212
• CAS Number: 347396-82-1
• Purity: ≥95%

Ranibizumab（Cat No.:I044212）is a humanized monoclonal antibody fragment (Fab) that binds to vascular endothelial growth factor A (VEGF-A), inhibiting its interaction with VEGF receptors on endothelial cells. By blocking VEGF-A, ranibizumab reduces abnormal blood vessel growth and vascular leakage in the retina. It is widely used to treat neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). Administered via intravitreal injection, ranibizumab helps preserve and improve vision, offering a targeted and effective therapy for vision-threatening retinal vascular disorders.